Observational Study on Gut Flora and COVID-19
This study is looking at the role of gut flora (the bacteria in your intestines) in COVID-19 infection. Researchers want to see if the virus that causes COVID-19, SARS-CoV-2, is found in the stool of infected patients. You might be able to join if you are 18 years or older and have been diagnosed with COVID-19 by an RT-PCR test within the last week. The study will consider itself successful if it can show a connection between the types of bacteria in your gut and the disease, measured by analyzing your stool over one year. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will watch and collect information without giving any new treatments. It plans to include 250 participants.
- What's involved
- In this study, your stool will be tested during your COVID-19 treatment and again after treatment.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one year to measure the correlation of microbiome to disease.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study to Explore the Role of Gut Flora in COVID-19 Infection
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Sabine Hazan, MD · PRINCIPAL_INVESTIGATOR · ProgenaBiome
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome SequencingOne year
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific gastrointestinal disease types.